Patient Alerts

Patient Plastic Surgery Updates

ASAPS and ASPS Issue Joint Position Statement on Stem Cells and Fat Grafting - Stem cells in aesthetic surgery promising, but marketing claims are too far ahead of the science

Boston, MA (May 9, 2011) – A joint task force of the two leading plastic surgery associations, the American Society for Aesthetic Plastic Surgery (ASAPS) and the American Society of Plastic Surgeons (ASPS), today released a position statement on the use of stem cells in aesthetic surgery during The Aesthetic Meeting 2011, the annual meeting of ASAPS. Based on a systematic review of the peer-reviewed literature, the task force concluded that while there is tremendous potential for the future use of stem cells in aesthetic surgical procedures, the scientific evidence and other data are very limited in terms of assessing the safety or efficacy of stem cell therapies in aesthetic medicine. The task force, led by plastic surgeon and noted expert on fat-derived stem cells, J. Peter Rubin, MD, of the University of Pittsburgh, was convened to address the growing concerns emerging from the plastic surgery community over advertising claims and clinical practices using stem cells that have not been substantiated by scientific evidence.

> Read more here

Backroom Procedures not Worth the Risk: Cosmetic Injectable Procedures Performed by Amateur Practitioners May Cause Pain, Disfigurement or Death

New York, NY (April 14, 2011) – The American Society for Aesthetic Plastic Surgery (ASAPS) has announced today that many consumers are still unaware of the risks associated with aesthetic procedures performed by unlicensed practitioners. Recent reports from Las Vegas, Philadelphia and other locations document unsuspecting patients suffering from pain and disfigurement and in the two recent cases, death, when women had their buttocks injected with unknown substances.

> Read more here

Aesthetic Society Applauds FDA’s Effort to Collect Data Concerning a Rare Condition Associated with Breast Implants

New York, NY (January 26, 2011) – The American Society for Aesthetic Plastic Surgery (ASAPS) announces today its support of a new national registry for breast implants that will be compiled by the American Society of Plastic Surgeons (ASPS) in collaboration with the Food and Drug Administration (FDA). This registry will document reported cases of a very rare condition, Anaplastic Large Cell Lymphoma (ALCL), in the presence of breast implants.

> Read more here